Teva Pharmaceuticals (@TevaUSA) / Twitter
John Nason - President, Teva Active Pharmaceutical Ingredients (TAPI) and Biologics Operations - Teva Pharmaceuticals | LinkedIn
Teva Pharma to raise $20 billion to $25 billion in bond sale next week: report | Reuters
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva CFO hopes for growth in 2022 - Globes
Teva to lay off 200 in Israel - Globes
Teva expands sustainability notes issue to $5b - Globes
Teva Pharmaceuticals - Wikiwand
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Asia Deal Watch: Innovent And Bolt Collaborate On Immune-Stimulating Antibody Conjugates :: Scrip
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
Teva Pharmaceuticals Honored with Klaus Tschira Human Resources Innovation Award from SAP | SAP News Center
18. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceuticals to Lay Off Upto 25% of Its Workforce in Israel | Communist Party of Israel
Analysts see upside in Teva share price - Globes
AbbVie and Teva Pharmaceuticals Are Being Scrutinized After the Valeant Controversy
